Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) Cash Flow Breakdown

GAIN THERAPEUTICS, INC Cash Flow Breakdown

Cash flow breakdown shows where GAIN THERAPEUTICS, INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $18.47M went out.
  • Fiscal year ended 2025-12-31: from financing, $28.45M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.46M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$18.47M$250.26K$28.20M*$10.46M
2024-12-31-$18.87M$4.98M$57.71K$12.95M*-$1.41M
2023-12-31-$18.87M$10.22M$12.64M*$4.49M
2022-12-31-$14.69M-$14.77M-$29.57M
2021-12-31-$12.37M-$94.21K$12.22K$41.75M*$29.41M
2020-12-31-$3.24M-$20.83K$738.28K$9.75M*$7.19M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-06-30-$4.68M*$1.37M*
2026-03-31-$4.73M-$4.30M
2025-12-31-$4.62M*$16.55M*
2025-09-30-$4.93M*$7.03M*
2025-06-30-$5.10M*$2.47M*
2025-03-31-$3.82M$2.40M*-$1.31M
2024-12-31-$3.45M*-$43.45K*$0.00*$2.31M*
2024-09-30-$6.08M*-$1.00*$0.00*$808.68K*
2024-06-30-$5.76M*$2.00M*$0.00*$10.04M*
2024-03-31-$3.59M$3.02M$57.71K-$1.16M
2023-12-31-$5.66M*$3.14M*$9.56M*
2023-09-30-$3.97M*$1.93M*$157.10K*
2023-06-30-$5.02M*$3.05M*$2.22M*
2023-03-31-$4.22M$2.11M$770.52K-$1.32M
2022-12-31-$3.90M*$133.83K*
2022-09-30-$3.29M*-$11.41K*
2022-06-30-$5.05M*-$14.89M*
2022-03-31-$2.45M-$7.83K-$2.54M
2021-12-31-$4.15M*-$11.10K*
2021-09-30-$2.19M*-$32.12K*
2021-06-30-$3.22M*-$22.50K*
2021-03-31-$2.81M-$28.49K$41.99M*$39.13M
2020-12-31-$1.31M*-$14.55K*$30.40K*
2020-09-30-$755.02K*-$1.42K*$423.29K*$9.12M*
2020-06-30-$424.19K*$38.00*$0.00*
2020-03-31-$752.82K-$4.90K$284.60K$1.11M*$631.41K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B